Delivery Order SPE2DR25D9223-SPE2DR26FFAH3
Award Date 4/24/26
Potential Completion Date 4/27/26
Potential Value $7.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $2,192.76 delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Lidocaine 5% Patch 30s. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group Inc....
- The Defense Logistics Agency issued a $1,461.84 delivery order to DMS Pharmaceutical Group Inc. on February 20, 2026, for Lidocaine 5% Patch 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a $2,192.76 delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for lidocaine 5% patch 30-count units. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. Place of performance is Park...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 24, 2026, for Lidocaine 5% Patch 30S with a ceiling value of $4,385.52, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. The underlying IDC carries a $499.999...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 11, 2026, for Lidocaine 5% Patch 30S with a ceiling value of $1,096.38, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The Defense Logistics Agency issued a $5,847.36 delivery order to DMS Pharmaceutical Group Inc. on February 19, 2026, for Lidocaine 5% Patch 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group is a woman-owned small business. The order carries a firm fixed-price structure with an ultimate completion date of February 20, 2026. Place of performance is Park Ridge, IL 60068. PPV-G GEN V is the Defense Logistics Agency's single-award...
- The Defense Logistics Agency issued a $3,654.60 delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, for Lidocaine 5% Patch 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Defense Logistics Agency's PPV-G GEN V indefinite delivery contract, a $499.999 billion program supporting pharmaceutical supply to Department of Defense healthcare facilities...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, for Lidocaine 5% Patch 30S with a ceiling value of $3,045.50, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 17, 2026, for Lidocaine 5% Patch 30S with a ceiling value of $3,654.60, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide. The order is firm fixed price with place of performance in Park Ridge, IL and...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 13, 2026, for Lidocaine 5% Patch 30s with a ceiling value of $1,096.38, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical...